Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma

Figure 2

Performance of the DRGS in predicting OS among clinical factors. (a) Subgroup analyses estimating the prognostic value of DRGS in different clinical factors. (b) KM analysis of the DRGS in the early-stage (I/II) ESCC patients. (c) KM analysis of the DRGS in the advanced-stage (III/IV) ESCC patients. (d) KM survival curves of OS among four patient groups stratified by the DRGS and residual tumor.

(a)

(b)

(c)

(d)